Program

Black Americans have roughly twice the incidence of multiple myeloma as 
white Americans, with recent studies finding that blacks are also less likely to receive 
the latest myeloma treatments or combination therapies, and are more likely to encounter 
delays in receiving treatment, including transplants. Participants attending this
program will learn about blood cancers impacting older adults, including myeloma.
The program will also address factors determining an appropriate treatment plan
for older adults, clinical trials, and communicating with one’s treatment team.
Resources available through The Leukemia & Lymphoma Society will be reviewed. 

 We encourage you to invite your caregiver and family members.